
<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <link rel="stylesheet" href="/static/styles/human.css" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
  </head>

<body>
  <div class="title-banner">Breast Clinical Care Pathway</div>
  <div class="frame">

  <div class="group-holder" role="list">

    <!------------------------- preop group ------------------------->
    <div class="group preop" role="listitem">
      <div class="groupheader">Preoperative</div>
      <div class="groupbody">
        
        <div class="subsection">
          <div class="dot"><img class="vicon" src="static/img/vector-1.svg"></div>
          <div class="subsection-header">NPO Guidelines</div>
          <div class="subsection-body"><ul>
<li>Stop full liquids 8 hrs prior to surgery</li>
<li>Stop water 2 hrs prior to surgery</li>
<li>Consider allowing breast patients who arrive early to pre-op for
lympho or mammography to drink water until 2 hrs prior to surgery</li>
</ul></div>
        </div>
        
        <div class="subsection">
          <div class="dot"><img class="vicon" src="static/img/vector-2.svg"></div>
          <div class="subsection-header">Labs</div>
          <div class="subsection-body"><ul>
<li>b-HCG for females patients under 66</li>
</ul></div>
        </div>
        
        <div class="subsection">
          <div class="dot"><img class="vicon" src="static/img/vector-3.svg"></div>
          <div class="subsection-header">Pain Medications</div>
          <div class="subsection-body"><p>Non-opioid analgesia adjuncts to consider: - Acetaminophen 1000mg
(caution with hepatic disease) - Gabapentin 300mg</p></div>
        </div>
        
      </div>
    </div>

      <!------------------------- intra group ------------------------->
    <div class="group intra" role="listitem">
      <div class="groupheader">Intraoperative</div>
      <div class="groupbody">
        
        <div class="subsection">
          <div class="dot"><img class="vicon" src="static/img/vector-2.svg"></div>
          <div class="subsection-header">PONV Prophylaxis Medications</div>
          <div class="subsection-body"><p>Especially important if patient Apfel socre 3 or 4:</p><ul>
<li>Aprepitant 30mg PO</li>
<li>Scopolamine patch (avoid in patients over 60 year of age)</li>
</ul></div>
        </div>
        
        <div class="subsection">
          <div class="dot"><img class="vicon" src="static/img/vector-2.svg"></div>
          <div class="subsection-header">Monitors</div>
          <div class="subsection-body"><ul>
<li>Standard monitors plus SEDline EEG for TIVA cases</li>
<li>Recommend core temperature monitoring for cases &gt;4 hrs</li>
<li>Tetragraph TOF for cases utilizing paralytics</li>
</ul></div>
        </div>
        
      </div>
    </div>

      <!------------------------- post group ------------------------->
    <div class="group post" role="listitem">
      <div class="groupheader">Postoperative</div>
      <div class="groupbody">
        
        <div class="subsection">
          <div class="dot"><img class="vicon" src="static/img/vector-1.svg"></div>
          <div class="subsection-header">Additional Medications</div>
          <div class="subsection-body"><p>Non-opioid adjuncts to consider</p><ul>
<li>Ketamine: 0.5mg/kg bolus +/- 2-5mcg/kg/min</li>
<li>Dexmedetomidine: consider bolus and/or infusion</li>
<li>IV acetaminophen: if acetaminophen not given in pre-op or &gt;6
hours from pre-op dose</li>
<li>Ketorolac 10-30mg: if Celecoxib not given in pre-op and when
surgeons approve</li>
</ul><p>Opioid selection:</p><ul>
<li>Consider methadone 0.1-0.2mg/kg for flaps</li>
</ul><p>Anti-emetics to consider:</p><ul>
<li>Dexamethasone 0.1mg/kg IV prior to incision</li>
<li>Ondansetron 4mg IV</li>
<li>Haloperidol 0.5-1mg or droperidol 0.625-2.5mg (assess QTc)</li>
</ul></div>
        </div>
        
        <div class="subsection">
          <div class="dot"><img class="vicon" src="static/img/vector-3.svg"></div>
          <div class="subsection-header">Post-op Analgesia</div>
          <div class="subsection-body"><ul>
<li>Fentanyl +/- hydromorphone IV PRN: decrease doses in setting of OSA
or respiratory compromise</li>
<li>Oxycodone PO</li>
</ul></div>
        </div>
        
      </div>
    </div>


    <div class="foot">
      Version XYZ. Last updated Feb 31, 2023. Available as a webpage at <a href="https://pathways.stanes.link/breast">https://pathways.stanes.link/breast</a> or as a <a href="https://pathways.stanes.link/breast/pdf">downloadable PDF</a>. Edit this pathway in <a href="https://office365stanford-my.sharepoint.com/:t:/g/personal/agoodell_stanford_edu/EWdDw2RJ_O5ApV4jNibrWLIBWoOl56xVz_Vpgiy6Ao9Aqg?e=asjnYw">OneDrive</a>.
    </div>
  </div>
  </div>


</body>

</html>